Pulmatrix (PULM) Receivables (2014 - 2025)
Pulmatrix (PULM) posted Receivables of $16000.0 for Q1 2025, down 30.43% sequentially from $23000.0 in Q3 2024, and down 97.19% YoY from $570000.0 in Q1 2024.
Pulmatrix (PULM) Receivables (2014 - 2025) Analysis & Trends
Pulmatrix has reported Receivables for 12 years, with the latest figure at $16000.0 in Q1 2025.
- Quarterly Receivables fell 97.19% year-over-year to $16000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $16000.0 (down 97.19% YoY) and the FY2023 annual result came in at $928000.0, down 28.51% from the prior year.
- Receivables retreated to $16000.0 in Q1 2025 per PULM's latest filing, from $23000.0 in the prior quarter.
- Over five years, Receivables peaked at $1.8 million in Q2 2021 and troughed at $9000.0 in Q3 2021.
- A 5-year average of $602000.0 and a median of $602500.0 in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2021 and 2022: Receivables tumbled 99.85% in 2021, then soared 5188.89% in 2022.
- Over 5 years, Receivables stood at $67000.0 in 2021, then soared by 1837.31% to $1.3 million in 2022, then slipped by 28.51% to $928000.0 in 2023, then slumped by 97.52% to $23000.0 in 2024, then tumbled by 30.43% to $16000.0 in 2025.
- According to Business Quant data, Receivables over the past three periods registered $16000.0, $23000.0, and $635000.0 for Q1 2025, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | - |
| 10 | Pulmatrix | 5.55 Mn | 5.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 16,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 635,000.00 |
| Mar 31, 2024 | 570,000.00 |
| Dec 31, 2023 | 928,000.00 |
| Sep 30, 2023 | 841,000.00 |
| Jun 30, 2023 | 418,000.00 |
| Mar 31, 2023 | 740,000.00 |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 476,000.00 |
| Jun 30, 2022 | 645,000.00 |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | 1.77 Mn |
| Mar 31, 2021 | 87,000.00 |
| Dec 31, 2020 | 45.08 Mn |
| Sep 30, 2020 | 1.22 Mn |
| Jun 30, 2020 | 353,000.00 |
| Dec 31, 2019 | 21.20 Mn |